A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice

International Clinical Psychopharmacology

Volumn 12, Issue 6, 1997, Pages 323-331

  Ekselius, L ^a   Von Knorring, L ^a   Eberhard, G ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Citalopram; Clinical study; Depression; General practice; Serotonin selective reuptake inhibitor; Sertraline

Indexed keywords

CITALOPRAM; SERTRALINE;

ADULT; AGED; AMNESIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0031417460     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199711000-00005     Document Type: Article

References (31)

1. Baldwin D, Thomas SC and Birtwistle J (1997) Effects of antidepressant drugs on sexual function. International Journal of Psychiatry in Clinical Practice, 1, 47-58.
2. Baumann P and Larsen F (1995) The pharmacokinetics of citalopram. Reviews in Contemporary Psychopharmacotherapy, 6, 287-295.
3. Bingefors KAL, Isacson D, von Knorring L and Smedby B (1995) Prescription drug and health care use among Swedish patients treated with antidepressants. Annals of Pharmacotherapy, 29, 566-572.
4. Danish University Antidepressant Group (DUAG) (1986) Citalopram. Clinical effect profile in comparison with clomipramine: a controlled multicenter trial. Psychopharmacology, 90, 131-138.
5. Danish University Antidepressant Group (DUAG) (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter trial. Journal of Affective Disorders, 18, 289-299.
6. Depression Guideline Panel (1993) Depression in Primary Care: Detection and Diagnosis. Clinical Practice Guideline, Number 5. U.S. Department for Health and Human Services Public Health Service, Agency for Health Policy and Research, Rockville, Maryland.
7. Editorial (1992) Depression and suicide: are they preventable? Lancet, 340, 700-701.
8. Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dubé S and Small G (1995) Sertraline safety and efficacy in major depression: a double-blind fixed dose comparison with placebo. Society of Biological Psychiatry, 38, 592-602.
9. Gram L and Stage K (1997) Dose, drop-out and symptomatology: important methodological problems in testing new antidepressants. Nordic Journal of Psychiatry, 51 (suppl 38), 27-31.
10. Guy W (1976) Clinical Global Impressions. In: ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, Rockville, Maryland, USA.
11. Hotopf M, Hardy R and Lewis G (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Jounal of Psychiatry, 170, 120-127.
12. Hyttel J, Arnt J and Sanchez C (1995) The pharmacology of citalopram. Reviews in Contemporary Psychopharmacotherapy, 6, 271-285.
13. Kasper S, Fuger J and Möller H-J (1992) Comparative efficacy of antidepressants. Drugs, 43 (suppl 2), 11-23.
14. Kerr JS, Sherwood NJ and Hindmarch I (1991) The comparative psychopharmacology of 5 HT reuptake inhibitors. Human Psychopharmacology, 6, 313-317.
15. Koe BK, Weissman A and Welch WM (1983) Sertraline, 1S, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. Journal of Pharmacology and Experimental Therapeutics, 226, 686-700.
16. Linggjaerde O, Ahlfors UG, Bech P, Dencker SJ and Elgen K (1987) The UKU-side effect rating scale. Acta Psychiatrica Scandinavia, 76 (suppl 334), 1-100.
17. Läkemedelsstatistik AB (1996) Medical Index Sweden. Läkemedelsstatistick AB, Stockholm, Sweden.
18. Malt U (1995) Practical Aspects of Long-Term Treatment. VIIIth Congress of the European College of Neuropsychopharmacology. Elsevier, Venice, Italy.
19. Marstrand B (1992) Brief Description of an HPLC-Method for Quantitative Determination of Citalopram and Two Metabolites, Desmethylcitalopram and Didemethylcitalopram in Serum and Urine. Lundbeck, Copenhagen, Denmark.
20. Medical Products Agency (1995) Pharmacotherapy for depression: recommendations [in Swedish]. Info från Läkemedelsverket, 6, 309-382.
21. Milne R and Goa K (1991) Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs, 41, 450-477.
22. Montgomery SA, Rasmussen JGC, Lyby K, Connor P and Tanghoy P (1992) Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. International Clinical Psychopharmacology, 6 (suppl 5), 65-70.
23. Murdoch D and McTavish D (1992) Sertraline: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder. Drugs, 44, 602-624.
24. Mårtensson B and Åberg-Wistedt A (1996) The use of selective serotonin reuptake inhibitors among Swedish psychiatrists. Nordic Journal of Psychiatry, 50, 443-450.
25. Ohrberg S, Christiansen PE and Severin B (1992) Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatrica Scandinavica, 86, 437-444.
26. Olie JP, Gunn KP and Katz E (1997) A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of depression. European Psychiatry, 12, 34-41.
27. Rosenberg C, Damsbo N, Fuglum E, Jacobsen LV and Horsgård S (1994) Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicenter clinical study. International Clinical Psychopharmacology, 9 (suppl 1), 41-48.
28. Rutz W, Wålinder J, Eberhard G, Holmberg G, von Knorring A-L, von Knorring L, Wistedt B and Åberg-Wistedt A (1989) An educational program on depressive disorders for general practitioners on Gotland: background and evaluation. Acta Psychiatrica Scandinavica, 79, 19-26.
29. Rutz W, von Knorring L, Wålinder J and Wistedt B (1990) Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs. Acta Psychiatrica Scandinavica, 82, 399-403.
30. Rutz W, Wålinder J, von Knorring L, Rihmer Z and Pihlgren H (1997) Prevention of depression and suicide: Gotland Study update. International Journal of Psychiatry in Clinical Practice, 1, 39-46.
31. Tylee A (1996) DEPRES (Depression Patient Research in European Society): The Patients' Perspective of Depression. 8th Congress of the Association of European Psychiatrists, London.